Skip to main content
IC
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
13.47
-0.27 (-1.97%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2021 FY 2019 FY 2018
Period Ending
 Dec '24 Dec '23 Dec '21 Dec '19 Dec '18
Therapeutics for Hematological, Pulmonary and Cardiovascular Disorders
3.55M
Log In
Log In
Log In
Log In
Therapeutics for Hematological, Pulmonary and Cardiovascular Disorders Growth
2250.99%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2021 FY 2019 FY 2018
Period Ending
 Dec '24 Dec '23 Dec '21 Dec '19 Dec '18
United States
3.55M
Log In
Log In
Log In
Log In
United States Growth
2250.99%
Log In
Log In
Log In
Log In